GlassScriptPhysician profile
Brian Scott Cope
NPI 1902893506
$3,622.75
in general payments reported to CMS, 2019-2025
23 companies · $501 in 2025
The $501 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $146 · 2021: $329 · 2022: $674 · 2023: $1,125 · 2024: $415 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,990 · Travel and Lodging: $52.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,989.78 |
| Travel and Lodging | $52.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $947.42 | 2021-2025 | Interstim |
| Boston Scientific Corporation | $787.15 | 2022-2023 | Lithovue, Spaceoar Vue System - 10ml, Rezum Generator |
| Axonics, INC. | $259.60 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $199.85 | 2019-2023 | Xtandi |
| Ambu INC. | $186.10 | 2022-2025 | |
| Medtronic USA, INC. | $185.05 | 2019-2020 | |
| Procept Biorobotics Corporation | $143.74 | 2019 | |
| Laborie Medical Technologies Corp. | $128.78 | 2025 | |
| Coloplast Corp | $121.34 | 2019-2025 | Speedicath |
| Antares Pharma, INC. | $100.00 | 2023 | Tlando, Xyosted |
| Merck Sharp & Dohme LLC | $74.72 | 2019 | |
| Abbvie INC. | $65.50 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $62.87 | 2022-2024 | Pylarify |
| Rochester Medical Corporation | $61.07 | 2022 | |
| Olympus America INC. | $52.48 | 2023-2024 | Itind System, Hd Camera Head |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $47.06 | 2024 | Irrisept |
| Welch Allyn | $41.43 | 2019 | |
| Teleflex LLC | $33.89 | 2023 | Urolift |
| Urovant Sciences INC | $30.86 | 2021-2022 | |
| Janssen Biotech, INC. | $27.96 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $27.32 | 2024 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $25.53 | 2024 | Gemtesa |
| Halozyme INC | $13.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.